Harry Connick Jr. plays his part to stop colon cancer screening procrastination

His wife, Jill Connick, also played a role in The New 50 campaign.

How removing an 's' can change the perception of migraines

Amgen and Novartis enlisted Arnold Worldwide, Wavemaker, and Starcom Media Group for its Speak Your Migraine campaign.

How Adapt Pharma tackled the opioid crisis head on

How Adapt Pharma tackled the opioid crisis head on

The firm's Narcan product is more than just a lifesaving treatment for opioid overdose. It's a brilliant, salient campaign, as well.

Vincent Bolloré arrested as part of probe into corruption allegations

Vincent Bolloré arrested as part of probe into corruption allegations

The billionaire recently stepped down as chairman of Vivendi.

Can the healthcare industry really expect to drive patient engagement?

Can the healthcare industry really expect to drive patient engagement?

Increasing patient engagement as a tool for improving care and outcomes has been a tough code to crack for the healthcare industry.

Five things for pharma marketers to know: Wednesday, April 25, 2018

Five things for pharma marketers to know: Wednesday, April 25, 2018

Takeda investors unhappy with preliminary Shire deal; New drug sales drive Amgen earnings; Novartis debuts mobile app for eye disease study.

Consultancies are 'in the room, but not winning,' says WPP digital leader

Consultancies are 'in the room, but not winning,' says WPP digital leader

But threats to the industry loom as brands take work in-house.

How and why the #KeeptheCare initiative came to be

How and why the #KeeptheCare initiative came to be

HealthyWomen's CEO dishes on the #KeeptheCare initiative, and the rigors of activism and advocacy in the digital age.

Five things for pharma marketers to know: Tuesday, April 24, 2018

Five things for pharma marketers to know: Tuesday, April 24, 2018

Express Scripts pressures Amgen on migraine medicine list price; Takeda, Shire get closer to deal; Sanofi R&D chief steps down.

Five things for pharma marketers to know: Monday, April 23, 2018

Five things for pharma marketers to know: Monday, April 23, 2018

Takeda makes higher offer for Shire; Prothena pulls plug on AL amyloidosis drug; Henry Schein to spin off animal health unit.

Sandoz signs on to lead launch of Pear's digital therapeutics

Sandoz signs on to lead launch of Pear's digital therapeutics

A deal with Sandoz to lead the global launch of Pear's two lead products puts marketing muscle behind the nascent class of 'prescription digital therapeutics.'

Lessons learned from going live on Facebook with a branded drug

Lessons learned from going live on Facebook with a branded drug

Novocure and Glue Advertising put on a Facebook Live event promoting the cancer treatment Optune in March.

Five things for pharma marketers to know: Friday, April 20, 2018

Five things for pharma marketers to know: Friday, April 20, 2018

Allergan reverses course on Shire deal; Merck seeks partners for cancer, immune system drugs; J&J diversified vision portfolio and it's paying off.

P&G: healthcare acquisition helps us stay on top of consumer 'megatrends'

P&G: healthcare acquisition helps us stay on top of consumer 'megatrends'

Procter & Gamble said its $4.2 billion acquisition of German firm Merck's consumer health division was about allowing it to respond to the changing demands of an aging world.

Private-equity funds dominate marcomms M&A

Private-equity funds dominate marcomms M&A

Nearly a quarter (22%) of all marcomms M&A deals involved private-equity funds — double the 11% seen in the last two quarters of 2017.

Five things for pharma marketers to know: Thursday, April 19, 2018

Five things for pharma marketers to know: Thursday, April 19, 2018

Allergan enters bidding war for Shire; Opioid prescriptions drop in 2017; Novartis Q1 numbers disappoint.

Read and Scott: 'We don't believe break-up of WPP makes sense'

Read and Scott: 'We don't believe break-up of WPP makes sense'

WPP's joint chief operating officers Mark Read and Andrew Scott have said they do not believe a break-up of the ad group makes sense.

Ogilvy CEO John Seifert on Martin Sorrell's exit: 'The show must go on'

Ogilvy CEO John Seifert on Martin Sorrell's exit: 'The show must go on'

Seifert said feedback from clients has been positive.

PBMs, drugmakers face off over copay accumulators

PBMs, drugmakers face off over copay accumulators

As with most drug pricing battles, patients yet again are caught in the crossfire.

Five things for pharma marketers to know: Wednesday, April 18, 2018

Five things for pharma marketers to know: Wednesday, April 18, 2018

Sanders introduces opioid bill; GW gets nod from FDA for Epidiolex; Sanofi sells generic unit to Advent for $2.4 billion.